This content is PDF only. Please click on the PDF icon to access.
When, in 1905, Fraenkel introduced intravenous therapy with strophanthin, he probably never thought that oral strophanthin, discredited and abandoned for valid reasons, would be revived in 1951.
On 382 pages, the benefits to be derived from strophanthin given orally are expounded. If the author has hoped to convince the skeptical reader by scientific argument and clinical examples, he has achieved exactly the opposite result. From the case histories presented, one gains the impression that many patients who have benefited subjectively from oral strophanthin ("Strophoral") did not suffer from any cardiovascular disorder at all but more likely from various forms and
Die orale Strophanthin Behandlung.. Ann Intern Med. 1951;35:1390. doi: 10.7326/0003-4819-35-6-1390_2
Download citation file:
Published: Ann Intern Med. 1951;35(6):1390.
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use